Definiens®, the leading provider of image analysis and data
mining solutions for quantitative digital pathology, today announced it will
expand its already comprehensive product portfolio with additional
stereological analysis methods. Stereology can be incorporated into both manual
and automated whole slide image analysis workflows. Find more under http://info.definiens.com/stereology.html
Stereology complements the unique combination
of flexibility and ease-of-use that makes Definiens Tissue Studio®
leading solution for analyzing histological samples. With the latest release of
Definiens Tissue Studio 3.5, systematic random sampling is now available out of
High productivity through end-to-end
automation is achieved by combining stereological methods with Definiens'
automated and precision detection of structure and morphology in heterogeneous
tissue. This significantly reduces user interaction and analysis time and delivers
unbiased and detailed readouts at the same time. Alternatively, semi-automatic
or manual stereology workflows can be applied wherever appropriate.
For three dimensional measurements, Definiens
also offers automated co-registration of serial tissue sections. Definiens
stereology solutions are compatible with all major slide image file formats on
the market and work with both bright field and fluorescence image data.
"Stereological methods are a long established
approach to obtaining quantitative data about three-dimensional features from
two dimensional tissue sections," says Thomas Heydler, CEO, Definiens.
"Definiens' offerings in image and data analysis provide biomedical
professionals with tools to significantly accelerate workflows and retrieve
unparalleled insights from tissue samples."
Visit Definiens at the USCAP's industry
exhibition, booth number 807, Vancouver, Canada, from March 17-23, 2012.
Definiens is the leading provider of image analysis and data mining
solutions for quantitative digital pathology in the life sciences, tissue
diagnostics and healthcare industries. Definiens software provides detailed
readouts from whole tissue slides, cell-based assays and full body scans and
allows correlating this information with data derived from other sources,
generating new knowledge and supporting better decisions in research,
diagnostics and therapy. By automating analysis workflows, Definiens provides
pharmaceutical and biotechnology companies, research institutions, clinical
service organizations and pathologists with deeper insights and faster results,
increasing speed to market and ROI. Harnessing the power of image intelligence,
Definiens makes possible new fields of research, supports the development of
personalized medicine and aims to significantly improve the quality of
Definiens is headquartered in Munich,
Germany, and has offices throughout the United States.